Hyaluronic Acid Vs. Biostimulators: Which Dermal Filler Is Right for You?

Industry Watch: Hyaluronic Acid vs. Biostimulators—Which Will Dominate the New Landscape of the Global Aesthetic Fillers Market?

The recently released 《2025 Global Medical Aesthetics Market Trends Report》highlights that, within the category of non-surgical aesthetic procedures, the global market share for "regenerative" biostimulators grew by 34.7% year-on-year—far outpacing the 18.2% growth rate of traditional hyaluronic acid fillers.Underlying this data is a reflection of the profound transformation currently sweeping through the medical aesthetics industry:——global aesthetic procedure trends are shifting from "immediate filling" toward "long-term regeneration." In the ongoing technological rivalry between hyaluronic acid vs biostimulators, which product is truly best suited for your business strategy? As a specialized supplier with over two decades of deep expertise in the medical aesthetics export sector, we present this industry report to you, drawing upon our in-depth observations of the European, Middle Eastern, and Southeast Asian markets.

Market Trends: Regenerative Medicine Emerges as a New Industry Hotspot

According to the latest statistics from the International Society of Aesthetic Plastic Surgery (ISAPS), biostimulatory products—exemplified by poly-L-lactic acid (PLLA)—saw a year-over-year increase of over 40% in clinical usage in 2024,making them the fastest-growing dermal filler types this trend is no mere coincidence. As the sophistication of aesthetic consumers evolves, relying solely on the effects of physical volume filling is no longer sufficient to satisfy their heightened demands for results that are "natural, long-lasting, and seamless."

At the recently concluded Dubai Derma exhibition, executives from numerous international aesthetic medicine institutions unanimously observed that the fundamental logic of how dermal fillers work is being redefined—shifting from "volumetric filling" to "biological regeneration." This implies that over the next five years, suppliers capable of offering both traditional hyaluronic acid dermal fillers and biostimulatory products will emerge as the market winners.

Foundational Understanding: The Evolution and Classification of Dermal Filler Types

Before delving into a detailed comparison, we must establish a shared understanding: while all dermal fillers aim to combat the signs of aging, their underlying mechanisms of action differ fundamentally. We can broadly categorize the mainstream products currently on the market into two groups: "physical fillers"—typified by Hyaluronic Acid (HA)—and "biostimulators"—typified by Poly-L-Lactic Acid (PLLA).

The former is akin to directly adding cushioning to a sagging sofa, yielding immediate results; the latter, conversely, resembles fertilizing soil to awaken the skin's own innate regenerative capacity. For professional aesthetic clinics and distributors, grasping the essence of these two distinct technologies serves as the cornerstone for providing expert consultation to their clients.

Technical Comparison: The Clinical Value of Two Mainstream Approaches

Instant Gratification: Hyaluronic Acid Fillers

Hyaluronic acid dermal fillers have long maintained a dominant position in the market, and their advantages lie in the following:

● Immediate Results: Improvement is visible immediately after injection, especially suitable for delicate areas such as the lips, tear troughs, and nasolabial folds.

● High Safety: Non-animal-derived cross-linking technology greatly reduces the risk of allergies and can be reversed by dissolving enzymes.

● Convenient Procedure: Relatively low skill requirement for doctors, suitable for standardized procedures.

However, its limitations are equally apparent: the effects typically last for only 6 to 18 months, necessitating frequent repeat purchases by consumers. For institutions seeking to cultivate long-term customer loyalty, this presents both an advantage—namely, a high rate of repeat business—and a challenge, as customers may switch to alternative options due to the rapid dissipation of results.

Long-lasting Regenerative Type: PLLA Biostimulator

Biostimulators centered on PLLA represent the future direction of aesthetic medicine. The core value of this product category lies in the following attributes:

● Activation of Endogenous Collagen: Rather than relying on mere physical volume displacement, these products awaken fibroblasts, enabling the skin to "regenerate itself."

● Durable and Natural Results: Offering long-lasting maintenance for over two years, the results are gradual and natural, thereby avoiding the risk of a "stiff" or artificial facial appearance.

● Tissue Reconstruction Capabilities: These products are ideally suited for addressing complex aesthetic concerns, such as significant volume loss and skin laxity associated with aging.

Combination products featuring both PLLA and HA—such as the 1mL PLLA-HA filler within our AOMA Aesthetics Series—achieve a significant breakthrough built upon this foundation. The HA component provides immediate gratification through instant volume enhancement, while the PLLA component initiates a long-term regenerative mechanism, thereby harmonizing "immediate results with enduring value."

Security

Both options offer an extremely high level of safety. HA carries a very low risk of allergic reactions and can be reversed using hyaluronidase. As a biostimulator, PLLA rarely triggers allergic reactions; furthermore, since its degradation product is lactic acid—a natural metabolite of the human body—it poses virtually no risk of long-term side effects. However, PLLA places higher demands on the injector's technique, requiring uniform and deep distribution to prevent the formation of nodules.

Frontline Case Studies: Authentic Voices from the Market

A Large Beauty Chain in Mexico City

As a pioneer in the Latin American market, this institution operates over 15 clinics across Mexico. Its Purchasing Director revealed to us: "Over the past two years, we have observed a significant increase in consumer acceptance of the 'regeneration concept.' Last year, we introduced AOMA’s PLLA-HA composite filler as a core product for our premium anti-aging treatments. A renowned local television presenter was among our very first clients to try it; after just three treatment sessions, not only did her nasolabial folds and sunken cheeks show marked improvement, but—to our pleasant surprise—her skin texture transformed from being lax and coarse to firm and radiant. She shared a year-long progress log on social media, which directly generated inquiries from over 50 new clients for us. Currently, revenue from our PLLA product line has risen from an initial 8% to 25% of our total medical aesthetics business."

Industry Watch: How to Choose Your Product Portfolio?

For large-scale beauty salons, cosmetic surgery hospitals, wholesalers, and exclusive distributors, the core logic for selecting a product line should be this: use HA to stabilize the core client base, and use PLLA to capture the high-end market.

From a procurement perspective, selecting a reliable hyaluronic acid dermal filler supplier is crucial; however, a more forward-looking strategy involves identifying a strategic partner capable of supplying both HA fillers and biostimulators. This approach not only meets your current business requirements but also positions you to effectively navigate market evolutions over the next five years.

Conclusion: Seizing Trends, Shaping the Future

As global aesthetic procedure trends shift from the "filling era" to the "regeneration era," which technological path should be chosen，This is no longer merely a choice at the product level, but rather a strategic decision bearing upon an institution's core competitiveness. We believe that suppliers capable of mastering both traditional hyaluronic acid dermal fillers and cutting-edge biostimulator technologies will emerge as the winners in this transformative shift.

As a medical aesthetics trading company with over two decades of export experience, we offer more than just products; we are dedicated to growing together with our partners. If you are seeking a trustworthy hyaluronic acid dermal filler supplier and wish to establish a product line featuring PLLA biostimulators—which represent the future of the industry—we invite you to contact us to obtain the latest market intelligence and sample support.

FAQ

Q1: Do biostimulators tighten skin?

A: Yes, but this represents a form of "inside-out" reconstructive tightening, rather than physical lifting. Biostimulators (such as PLLA) are not, in themselves, tightening agents; their mechanism of action lies in activating fibroblasts and stimulating the neogenesis of Type I and Type III collagen.

Q2: What are the risks of biostimulators?

A:Biostimulators have a well-established safety record; however, the associated risks depend primarily on the practitioner's technique. Taking PLLA as an example, if the injection depth is too superficial or the distribution is uneven, small, palpable subcutaneous nodules may occur. Nevertheless, such occurrences are extremely rare when the procedure is performed by experienced physicians, and they are typically reversible or resolve spontaneously. Unlike hyaluronic acid, PLLA does not have a corresponding dissolving enzyme; therefore, selecting a compliant product and a professional, reputable clinic is of paramount importance.

Q3: Is hyaluronic acid ok for daily use?

A:It is necessary to distinguish between two scenarios: "topical application" and "injection." As a skincare ingredient, topical hyaluronic acid is safe and suitable for daily moisturizing. However, hyaluronic acid dermal fillers are classified as Class III medical devices; they must be administered by a qualified medical professional in a sterile environment and should not be self-administered.

Q4: What is the natural source of hyaluronic acid?

A:Hyaluronic acid occurs naturally in the human body—specifically in connective tissues, the dermal layer of the skin, the vitreous humor of the eye, and synovial fluid within the joints. While early forms were extracted from animal tissues such as rooster combs, modern medical-grade hyaluronic acid is predominantly produced using non-animal-derived bio-fermentation techniques. This approach not only eliminates the risk of allergic reactions associated with animal-derived proteins but also enables standardized production characterized by controllable molecular weights and precisely regulated degrees of cross-linking.。

Q5: Can I use both vitamin C and hyaluronic acid together?

A:Yes, and this constitutes a classic synergistic combination. Topical Vitamin C (specifically L-ascorbic acid) acts as a potent antioxidant, helping to combat photoaging and stimulate collagen synthesis; hyaluronic acid, meanwhile, functions to bind moisture and maintain the skin's hydration levels. When used in tandem, these two ingredients deliver a dual benefit in skincare: "protection plus hydration." However, in the case of injectable hyaluronic acid fillers, it is advisable to strictly follow your physician's post-treatment care instructions, specifically by avoiding the application of high-concentration or potentially irritating ingredients to the injection sites.